Chief Innovation Officer, Faruk Capan, was recently quoted in an Endpoints News article, ChatGPT and generative AI land in pharma marketing with sense of awe — and plenty of caution. Check out the summary below, or access the full article to read the content in its entirety.
Generative AI has become an exciting tool for pharma marketers, as it can create original articles, social media content, illustrations or instructional videos in minutes. It is being used to simplify production, cut costs and assist in brainstorming. However, it is necessary to be cautious when using it, as the application relies on data sets that can be inaccurate or biased, and the application may try to bridge gaps by making up nonsense.
Pharma marketers must ensure the content is ‘pharmatized’, that it is accurate, correct and looked over by a real person. While it can do almost anything, marketers must be transparent in its use and be aware of potential issues. Generative AI is an exciting tool with endless potential, and with the right precautions and oversight, it can be used to its fullest.
“AI won’t replace you, a person using AI will.” – Faruk Capan